BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2017

Feb 28, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2017-02-24

Reporting Person: FUCHS HENRY J (President, Worldwide R&D)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-02-24	Common Stock	A	14564	—	Acquired	128442	Direct
2017-02-24	Common Stock	M	15000	$26.49	Acquired	143442	Direct
2017-02-24	Common Stock	S	15000	$87.99	Disposed	128442	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-02-24	Stock Option (Right to buy Common Stock)	$26.49	M	15000	Disposed	2021-05-11	Common Stock (15000)	Direct

Footnotes

F1: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F2: Represents the total number of RSUs earned pursuant to a calculation based on the level of the Issuer's total adjusted revenues for the fiscal year ended December 31, 2016, as certified by its audited financials, set forth in the performance-based RSU awards previously granted under the Issuer's 2006 Share Incentive Plan.

F3: Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 15, 2017, 2018 and 2019, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain corporate events.

F4: Trade made pursuant to a 10b5-1 plan executed on May 12, 2016.

F5: All shares were sold at the same price.

F6: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.